Lau C, LaBorde K, Fatima B, Alfartosy SS, et al. Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor-positive breast cancer. Breast Cancer Res Treat 2025 Apr 16. doi: 10.1007/s10549-025-07701.
PMID: 40237878